Alexion Pharmaceuticals, Inc. (ALXN)

[stocktrader001]

1. Alexion Pharmaceuticals, Inc. (ALXN): Drug Manufacturers Industry. Market cap of $7.66B. Street Insider and Benzinga identified the company as a takeover target. Analyst rating has changed from 1.41 to 1.67 over the last three months. Short float at 5.41%, which implies a short ratio of 5.43 days. The stock has gained 80.44% over the last year.

Read more: http://community.nasdaq.com/News/2011-01/12-takeover-targets-seeing-worsening-analyst-sentiment.aspx?storyid=54088#ixzz1FNvkRS4X